Table 2.
Total MSM (n=482) | MSM not engaged in RAIa (N=264) | MSM engaged in RAIa (N=185) | |||||||
---|---|---|---|---|---|---|---|---|---|
Prevalence | Circumcised (n=64) | Uncircumcised (n=418) | p | Circumcised (n=33) | Uncircumcised (n=231) | p | Circumcised (n=31) | Uncircumcised (n=154) | p |
HIV | 10.9 | 17.8 | 0.211 | 0.0 | 14.8 | 0.020 | 22.6 | 24.0 | 1.000 |
HBV | 24.6 | 22.0 | 0.633 | 15.6 | 18.3 | 1.000 | 32.3 | 28.6 | 0.670 |
HCV | 1.6 | 8.4 | 0.069 | 3.0 | 11.3 | 0.219 | 0.0 | 3.9 | 0.592 |
T. pallidum | 25.0 | 19.9 | 0.325 | 25.0 | 13.4 | 0.108 | 22.6 | 30.3 | 0.516 |
HPV | 88.9 | 81.2 | 0.733 | 75.0 | 85.7 | 0.527 | 92.3 | 79.7 | 0.442 |
RAI with men and/or trans.
MSM, men who have sex with men; RAI, receptive anal intercourse; HIV, human immunodeficiency virus; HBV, hepatitis B; HCV, hepatitis C; HPV, human papillomavirus.
Statistically significant associations are illustrated in boldface.